<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00909714</url>
  </required_header>
  <id_info>
    <org_study_id>NETS Trial</org_study_id>
    <nct_id>NCT00909714</nct_id>
  </id_info>
  <brief_title>Neuroregeneration Enhanced by Transcranial Direct Current Stimulation (TDCS) in Stroke</brief_title>
  <acronym>NETS</acronym>
  <official_title>Neuroregeneration Enhanced by TDCS in Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Testing the hypothesis that non-invasive brain stimulation by transcranial direct current
      stimulation (tDCS) combined with functional training in the subacute phase of first-ever
      stroke will enhance functional regeneration compared with a Placebo intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Stroke is the leading cause of long-term disability, which significantly impairs the economic
      and social life of patients and society. Every year 200 000 to 250 000 patients suffer a
      stroke in Germany. Only a small number of the stroke survivors recover to a degree that
      allows them to return into their professional and private life. Despite significant efforts
      to develop novel and efficient treatment strategies the level of functional regeneration is
      still not satisfying. Thus, the development of innovative and effective treatment strategies
      will have a major impact for the patients' life, the society and the public health system.

      Within the proposed project an innovative, non-invasive and cost effective interventional
      strategy, based on the combination of a specific rehabilitative training and brain
      stimulation by transcranial direct current stimulation (tDCS), will be used to enhance
      functional regeneration in stroke patients. The intervention will be applied in an early
      stage in which plasticity, cortical reorganization and functional improvement is most
      pronounced. We hypothesize that the combination of anodal tDCS delivered to the motor cortex
      of the affected hemisphere combined with training over a period of two weeks in the subacute
      stage after stroke will significantly enhance cortical plasticity, functional regeneration
      and long-term outcome determined by clinical and functional outcome measures compared with
      Placebo stimulation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Upper Extremity Fugl-Meyer-Assessment (UEFMA)</measure>
    <time_frame>1 day after the end of the 2-weeks intervention</time_frame>
    <description>standardized test of upper extremity function</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Upper Extremity Fugl-Meyer-Assessment (UEFMA)</measure>
    <time_frame>30 days, 90 days, and 12 months after the intervention</time_frame>
    <description>standardized test of upper extremity function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Action Research Arm Test (ARAT)</measure>
    <time_frame>1 day, 30 days, 90 days, and 12 months after the intervention</time_frame>
    <description>standardized tests of upper extremity function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nine Hole Peg Test (NHPT)</measure>
    <time_frame>1 day, 30 days, 90 days, and 12 months after the intervention</time_frame>
    <description>standardized test to assess fine motor skills</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke Impact Scale (SIS)</measure>
    <time_frame>1 day, 30 days, 90 days, and 12 months after the intervention</time_frame>
    <description>questionnaire is to evaluate how stroke has impacted health and life of patients</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>DC-Stimulator to apply tDCS + Training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>DC-Stimulator to apply Sham tDCS (Placebo) + Training</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DC-Stimulator to apply tDCS</intervention_name>
    <description>Anodal tDCS (20 minutes) stimulation will be applied once a day in combination with standardized upper extremity rehabilitative training</description>
    <arm_group_label>tDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DC-Stimulator to apply Sham tDCS</intervention_name>
    <description>Sham stimulation will be applied once a day in combination with standardized upper extremity rehabilitative training</description>
    <arm_group_label>Sham tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subacute stroke patients (5-45 days after stroke, age&gt;18 years) with thromboembolic
             non-hemorrhagic subcortical or cortical, clinically overt first-ever strokes will be
             included. Moderate to moderately severe upper-extremity hemiparesis, defined as an
             Upper Extremity Fugl-Meyer score (UEFMA) between 20 and 58 (inclusive).

        Exclusion Criteria:

          -  pre-existing large lesions (&gt; 1.5 cm maximum diameter in a brain area that belongs to
             the anatomically established sensorimotor/premotor system

          -  progressive stroke

          -  completely lesioned hand knob area of M1affected if no motor evoked potentials (MEPs)
             elicited by transcranial magnetic stimulation (TMS) are present

          -  bilateral motoric impairment

          -  florid alcohol and/or drug abuse

          -  florid severe psychiatric illness (e.g. schizophrenia)

          -  severe language disturbances that prevents the patient to give informed consent or
             inhibit adequate scoring because of insufficient understanding of scoring
             introductions

          -  tumor diseases with a life expectancy less than one year

          -  increased intracranial pressure

          -  polyneuropathy and/or ischemic peripheral disease if the sensorimotor functions of the
             upper extremities are affected clinically relevant

          -  severe cognitive deficits (MMSE ≤ 23)

          -  pregnancy

          -  contraindication for MRI or TMS
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Gerloff, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurology, University Medical Center Hamburg-Eppendorf</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christian Gerloff, Prof. Dr.</last_name>
    <phone>+49(0)40 741053770</phone>
    <email>gerloff@uke.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robert Schulz, Dr.</last_name>
    <phone>+49(0)40 741053770</phone>
    <email>r.schulz@uke.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Brandenburgklinik Berlin-Brandenburg</name>
      <address>
        <city>Bernau bei Berlin</city>
        <state>Berlin</state>
        <zip>16321</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Jöbges, Prof. Dr.</last_name>
      <phone>+49(0)333973400</phone>
      <email>joebges@brandenburgklinik.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Neurologische Klinik Bad Aibling</name>
      <address>
        <city>Bad Aibling</city>
        <zip>83043</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jürgen Dressnandt, Dr.</last_name>
      <phone>+49(0)80619031510</phone>
      <email>jdressnandt@Schoen-Kliniken.de</email>
    </contact>
    <contact_backup>
      <last_name>Barbara Schäpers</last_name>
      <phone>+49(0)80619031952</phone>
      <email>bschaepers@schoen-kliniken.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Moritz-Klinik</name>
      <address>
        <city>Bad Klosterlausnitz</city>
        <zip>07639</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Farsin Hamzei, Prof. Dr.</last_name>
      <phone>+49(0)3660149470</phone>
      <email>farsin.hamzei@moritz-klinik.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Neurologisches Zentrum Segeberger Kliniken</name>
      <address>
        <city>Bad Segeberg</city>
        <zip>23795</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Björn Hauptmann, Dr.</last_name>
      <phone>+49(0)45518026853</phone>
      <email>bjoern.hauptmann@segebergerkliniken.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>MEDIAN Klinik Berlin-Kladow</name>
      <address>
        <city>Berlin</city>
        <zip>14089</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Dohle, Dr.</last_name>
      <phone>+49(0)3036503102</phone>
      <email>christian.dohle@median-kliniken.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center Hamburg Eppendorf (UKE)</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Schulz, Dr.</last_name>
      <phone>+49(0)40741053770</phone>
      <email>r.schulz@uke.de</email>
    </contact>
    <contact_backup>
      <last_name>Julia Hoppe, Dr.</last_name>
      <phone>+49(0)40741053770</phone>
      <email>j.hoppe@uke.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University Medical Center Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Gutschalk, Prof. Dr.</last_name>
      <phone>+49(0)6221567504</phone>
      <email>Alexander.Gutschalk@med.uni-heidelberg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fondazione Santa Lucia</name>
      <address>
        <city>Rome</city>
        <zip>00179</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giacomo Koch, Prof. Dr.</last_name>
      <phone>+39(0)651501181</phone>
      <email>giakoch@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
  </location_countries>
  <removed_countries>
    <country>Austria</country>
    <country>France</country>
    <country>Switzerland</country>
  </removed_countries>
  <reference>
    <citation>Hummel F, Celnik P, Giraux P, Floel A, Wu WH, Gerloff C, Cohen LG. Effects of non-invasive cortical stimulation on skilled motor function in chronic stroke. Brain. 2005 Mar;128(Pt 3):490-9. Epub 2005 Jan 5.</citation>
    <PMID>15634731</PMID>
  </reference>
  <reference>
    <citation>Wessel MJ, Zimerman M, Timmermann JE, Heise KF, Gerloff C, Hummel FC. Enhancing Consolidation of a New Temporal Motor Skill by Cerebellar Noninvasive Stimulation. Cereb Cortex. 2016 Apr;26(4):1660-7. doi: 10.1093/cercor/bhu335. Epub 2015 Jan 20.</citation>
    <PMID>25604611</PMID>
  </reference>
  <reference>
    <citation>Schulz R, Gerloff C, Hummel FC. Non-invasive brain stimulation in neurological diseases. Neuropharmacology. 2013 Jan;64:579-87. doi: 10.1016/j.neuropharm.2012.05.016. Epub 2012 Jun 9. Review.</citation>
    <PMID>22687520</PMID>
  </reference>
  <reference>
    <citation>Zimerman M, Heise KF, Hoppe J, Cohen LG, Gerloff C, Hummel FC. Modulation of training by single-session transcranial direct current stimulation to the intact motor cortex enhances motor skill acquisition of the paretic hand. Stroke. 2012 Aug;43(8):2185-91. doi: 10.1161/STROKEAHA.111.645382. Epub 2012 May 22.</citation>
    <PMID>22618381</PMID>
  </reference>
  <reference>
    <citation>Hummel FC, Celnik P, Pascual-Leone A, Fregni F, Byblow WD, Buetefisch CM, Rothwell J, Cohen LG, Gerloff C. Controversy: Noninvasive and invasive cortical stimulation show efficacy in treating stroke patients. Brain Stimul. 2008 Oct;1(4):370-82. doi: 10.1016/j.brs.2008.09.003. Epub 2008 Oct 9. Review.</citation>
    <PMID>20633395</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 12, 2009</study_first_submitted>
  <study_first_submitted_qc>May 27, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 28, 2009</study_first_posted>
  <last_update_submitted>June 22, 2017</last_update_submitted>
  <last_update_submitted_qc>June 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>non-invasive cortical stimulation</keyword>
  <keyword>motor recovery</keyword>
  <keyword>cortical plasticity</keyword>
  <keyword>TDCS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

